<Suppliers Price>

Gefitinib D8

Names

[ CAS No. ]:
857091-32-8

[ Name ]:
Gefitinib D8

Biological Activity

[Description]:

Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells[1][2].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> JAK/STAT Signaling >> EGFR
Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
Signaling Pathways >> Autophagy >> Autophagy

[Target]

IC50: 37 nM (Tyr1173 site, in NR6wtEGFR cells), 37 nM (Tyr992 site, in NR6wtEGFR cells)[1]


[References]

[1]. Pedersen MW, et al. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br J Cancer. 2005 Oct 17;93(8):915-23.

[2]. Moasser MM, et al. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 2001 Oct 1;61(19):7184-8.

Chemical & Physical Properties

[ Molecular Formula ]:
C22H16D8ClFN4O3

[ Molecular Weight ]:
454.95200

[ Exact Mass ]:
454.20200

[ PSA ]:
68.74000

[ LogP ]:
4.28650

Related Compounds